30
June
2021
|
16:14 PM
Europe/Amsterdam

Dr. Partington Elected to Journal of Neurosurgery: Pediatrics Editorial Board

Michael D. Partington, MD, Pediatric Neurosurgeon, was recently elected to a six-year term on the editorial board of the Journal of Neurosurgery: Pediatrics. Dr. Partington is the first Children’s Mercy neurosurgeon to ever serve on the board of this scholarly publication.

“This is an opportunity to be among the first to see the state-of-the-art literature being produced in pediatric neurosurgery and to be a part of the process of determining what goes on to be published,” Dr. Partington said.

“Dr. Partington’s election to the editorial board is a significant and well-deserved achievement that reflects his editorial skills and deep understanding of our specialty,” said Paul Grabb, MD, Section Chief, Neurosurgery.

The Journal of Neurosurgery: Pediatrics is an independent monthly publication that has become the foremost journal in its subspecialty, offering comprehensive coverage of pediatric neurosurgery and related fields. Previously, Dr. Partington served as a reviewer for the journal.

Congrats to Dr. Partington on this new distinguished position!

About Us

Children’s Mercy Kansas City is an independent, non-profit, 386-bed pediatric health system, providing over half a million patient encounters each year for children from across the country. Children’s Mercy is ranked by U.S. News & World Report in nine specialties. We have received Magnet® recognition five times for excellence in nursing services. In affiliation with the University of Missouri-Kansas City, our faculty of more than 800 pediatric specialists and researchers is actively involved in clinical care, pediatric research and educating the next generation of pediatricians and pediatric subspecialists. The Children’s Mercy Research Institute (CMRI) integrates research and clinical care with nationally recognized expertise in genomic medicine, precision therapeutics, population health and health care innovation. In 2021 the CMRI moved into a nine-story, 375,000-square-foot space emphasizing a translational approach to research in which clinicians and researchers work together to accelerate the pace of discovery that enhances care.